A Phase III, Multicenter, Randomized, Placebo-Controlled Trial of Plerixafor, Plus G-CSF for Hematopoietic Stem Cell Mobilization in Non-Hodgkin’s Lymphoma Patients Undergoing Autologous Transplantation. The gene discussed is CSF3; the disease is non-Hodgkin lymphoma.